Description | Heather Greenlee, ND, PhD, MPH Associate Member, Cancer Prevention Program, Public Health Sciences Division, Fred Hutchinson Cancer Research Center This event will be held online via Zoom. The seminar will begin at 3:30 PM and you can attend via the following link: washington.zoom.us… A healthy dietary pattern and regular physical activity have been associated with better cancer outcomes for many cancers. However, it has proven difficult to identify effective strategies to achieve and maintain behavior change in cancer patient populations. Dr. Greenlee will discuss her ongoing work that focuses on identifying effective diet and physical activity behavior change interventions for cancer survivors. She will discuss the Mi Vida Saludable (My Health Life) trial, a diet and physical activity trial among Latina breast cancer survivors in New York City. She will also discuss two ongoing trials in the Pacific Northwest – one among breast cancer survivors at the Seattle Cancer Alliance and one among cancer survivors in the Lower Yakima Valley. Heather Greenlee, ND, PhD, MPH is an Associate Member in the Public Health Sciences and Clinical Research Divisions at the Fred Hutchinson Cancer Research Center and is an Associate Professor of Medicine in the Division of Medical Oncology at the University of Washington School of Medicine. She also serves as the Medial Director of the Integrative Medicine Service at the Seattle Cancer Care Alliance. Dr. Greenlee trained in epidemiology at the University of Washington and Columbia University and in naturopathic medicine at Bastyr University. Dr. Greenlee’s research focuses on the use of lifestyle modifications and complementary and integrative medicine for cancer prevention and control. She uses observational studies and clinical trials to study what cancer survivors can do, in addition to conventional treatment, to prevent cancer recurrence, decrease side effects of treatment, and improve prognosis. Dr. Greenlee is an active member of SWOG within the National Cancer Institute’s National Cancer Clinical Trials Network and is Past President of the Society for Integrative Oncology. Her work is funded by the National Cancer Institute and she is an inaugural recipient of the Washington State Cancer Research Distinguished Researcher Grant. |
---|